Search
Rethinking How Cancer Cells Evade Targeted Therapy
Glioblastomas (GBMs) are incurable brain tumors with a prognosis of about one-and-a half years on average. They are highly resistant to treatment and have defied all attempts at precision therapy.International Hematologic Conference Features UCSF Health Experts
Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 64th Annual Meeting and Exposition.UCSF Research Instrumental in Approval of Breakthrough Diabetes Therapy
The US Food and Drug Administration (FDA) recently approved the use of a new drug Teplizumab, an immunotherapy drug which has been shown to significantly delay the onset of type 1 diabetes.International Conference Features UCSF Breast Cancer Experts
Breast cancer experts from UCSF Health presented new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference.UCSF Cancer Specialist Recognized with Luminary Award for Gastrointestinal Cancers
Alan P. Venook, MD, a renowned expert in colorectal and liver cancers, has been announced as one of the winners of the 2022 Luminary Awards in Gastrointestinal (GI) Cancers.UCSF Researchers Develop Prediction Model of Aortic Aneurysm
Ascending thoracic aortic disease is an important cause of sudden death in the U.S., yet most aortic aneurysms are identified incidentally.UCSF Health Reaches 20,000 Organ Transplants
UC San Francisco surgeons have performed the health system’s 20,000th solid organ transplant, making it just the third in the nation to reach that milestone.Advanced Heart Failure Comprehensive Care Center Physician Pocket Card
Referral guide and contact information for advanced heart failure specialists at UCSF.Research Reveals Mechanisms at Work in Progression of Pancreatic Cysts to Pancreatic Cancer
Tumor Immune Microenvironments May Provide Clues to Future TherapiesMigraine Sufferers Are Prone to BPPV at an Earlier Age, Study Finds
Migraine predisposes individuals to developing benign paroxysmal positional vertigo (BPPV) earlier in life than those without migraine, according to a UCSF study.Cerebrovascular Neurosurgery
As one of the highest volume and most experienced surgical programs in the nation for cerebrovascular disorders, we offer a wide range of treatment options tailored to each patient, leading to safer surgeries and better outcomes.Screening and Removal of Precancerous Lesions Prevents Anal Cancer
National study led by UCSF is first to show effectiveness of simple strategies to reduce risk of often silent cancer.UCSF Sheds Light on the Reasons Behind Sex Differences in Myocarditis
This study suggests mechanisms behind why myocarditis associated with cancer immunotherapies may occur more frequently in female patients.UCSF Launches Initiative to Address Disparities in Pulse Oximetry Performance
This project seeks to improve accuracy for patients with darker skin pigmentation.UCSF Surgeons Perform First Pure Robotic Whipple Surgery in the Bay Area
Gastrointestinal surgeons at UC San Francisco have performed the first pure robotically assisted Whipple surgery in San Francisco.UCSF Develops First of Its Kind Robotic Surgery Trial in Partnership with FDA
UCSF Health is recruiting patients for the only FDA-approved study of the use of single port robotic technology for colorectal surgery in the United States.Advanced Heart Failure Comprehensive Care Center
The Advanced Heart Failure Comprehensive Care Center (AHF CCC) at UCSF offers coordinated and comprehensive care for heart failure patients.New Guidance for Reducing Medication-Related Dementia Risk in Patients With Overactive Bladder
This consensus paper is designed to update urologists and other healthcare providers who prescribe anticholinergics about the risks of these medications and help guide them on when to use anticholinergics and when it is appropriate to use alternatives.The First Patient-Centered Sialadenitis Assessment Tool
A new standardized measure of symptoms associated with salivary duct obstruction was recently developed by researchers, including UCSF otolaryngologists Jolie Chang, MD, FACS, and William R. Ryan, MD, FACS, and UCSF medical student Arushi Gulati.Spine Center
The UCSF Spine Center offers comprehensive management for all disorders of the spine, spinal cord and nerve roots.Autoantibody for Acquired Lipodystrophy Identified, Bringing Hope for Therapeutics
UCSF investigators have found an autoantibody biomarker for acquired lipodystrophy, paving the way for novel treatment options for this complex condition, which causes adipose tissue loss and metabolic complications.Genomic Sequencing Is Changing Diagnosis, Treatment for Patients with Brain Cancer
Patients diagnosed with a type of brain tumor survived for longer when they were treated aggressively with surgery, radiation and chemotherapy.Focal High-Intensity Focused Ultrasound Ablation for Intermediate-Risk Prostate Cancer
The urologic surgical oncology team has performed an average of five focal HIFU procedures a month since the device was installed last year, offering patients a new minimally invasive treatment option.Quality Improvement Yields Better-Than-Expected Mortality Rates at UCSF
At the UCSF Heart and Vascular Center, the adult inpatient mortality rates are better than expected across all services. These positive outcomes are driven by the team’s structured approach to quality improvement.